Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

about

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

Item

http://www.wikidata.org/entity/Q59132638

description

scientific article published on 14 November 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@en

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@nl

type

Item

label

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@en

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@nl

prefLabel

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@en

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@nl

P1476

Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma

@en

P2093

Alexandra V Sen'kova

http://www.w3.org/2001/XMLSchema#string

Alexey A Belogurov

http://www.w3.org/2001/XMLSchema#string

Dmitry D Genkin

http://www.w3.org/2001/XMLSchema#string

Elena L Chernolovskaya

http://www.w3.org/2001/XMLSchema#string

Hongkai Zhang

http://www.w3.org/2001/XMLSchema#string

Ivan V Chernikov

http://www.w3.org/2001/XMLSchema#string

Maria P Rubtsova

http://www.w3.org/2001/XMLSchema#string

Marina A Zenkova

http://www.w3.org/2001/XMLSchema#string

Oleg V Markov

http://www.w3.org/2001/XMLSchema#string

Teresa Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells

Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic effects.

Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity

Self-antigen recognition by follicular lymphoma B-cell receptors.

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

Germinal centres and B cell lymphomagenesis.

Follicular lymphoma: evolving therapeutic strategies.

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.

The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.

Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity.

P304

eaau4580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIADV.AAU4580

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30443597

http://www.w3.org/2001/XMLSchema#string

P932

6235538

http://www.w3.org/2001/XMLSchema#string